Our mission is to understand the unique goals of our clients so that we can facilitate the right strategic partnerships that create maximum value for an M&A exit.
Select Transactions
US-based MedTech company focused on innovative bipolar energy technologies targeting the minimally invasive treatment of hemorrhoids for use by gastroenterologists and colorectal surgeons.
Our Mandate
M&A transaction advisory, strategic company positioning and execution consulting as COO/VP of Sales.
Acquired by COVIDIEN Plc (subsequently acquired by MEDTRONIC Plc).
UK-based MedTech company
offering novel bipolar energy devices for use in radiology and GI endoscopy for treatments in liver ablation and palliative care of patients with pancreaticobiliary cancers.
Our Mandate
M&A transaction advisory and
strategic company positioning.
Acquired by Boston Scientific Corporation.
US-based MedTech company providing an endoluminal surgical platform targeting interventional gastroenterologists, colorectal, bariatric, and foregut surgeons.
Our Mandate
M&A transaction advisory, strategic company positioning and execution consulting as COO.
Acquired by Boston Scientific Corporation.
US-based MedTech company offering a state-of-the art platform in spinal implant plate and interbody systems.
Our Mandate
M&A transaction advisory and strategic company positioning.
Acquired by Spineart SA Switzerland.